Literature DB >> 12183595

Chlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice.

Erwin Blessing1, Lee Ann Campbell, Michael E Rosenfeld, Cho-chou Kuo.   

Abstract

Chlamydia pneumoniae has been shown to accelerate atherosclerotic lesion development in hyperlipidemic animals. This study showed that C. pneumoniae did not accelerate lesion development in mice if a high-fat/high-cholesterol diet was started after infection, indicating that C. pneumoniae is a co-risk factor with hyperlipidemia for cardiovascular disease.

Entities:  

Mesh：

Year:  2002        PMID： 12183595      PMCID： PMC128267          DOI： 10.1128/IAI.70.9.5332-5334.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  17 in total

1.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

2.  Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.

Authors:  K Aalto-Setälä; K Laitinen; L Erkkilä; M Leinonen; M Jauhiainen; C Ehnholm; M Tamminen; M Puolakkainen; I Penttilä; P Saikku
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

3.  Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.

Authors:  G Caligiuri; M Rottenberg; A Nicoletti; H Wigzell; G K Hansson
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

4.  De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model.

Authors:  I W Fong; B Chiu; E Viira; D Jang; J B Mahony
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  T C Moazed; L A Campbell; M E Rosenfeld; J T Grayston; C C Kuo
Journal:  J Infect Dis       Date:  1999-07       Impact factor: 5.226

6.  Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice.

Authors:  E Blessing; T M Lin; L A Campbell; M E Rosenfeld; D Lloyd; C Kuo
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

7.  Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice.

Authors:  E Blessing; L A Campbell; M E Rosenfeld; N Chough; C C Kuo
Journal:  Atherosclerosis       Date:  2001-09       Impact factor: 5.162

8.  Atherosclerosis in apoE knockout mice infected with multiple pathogens.

Authors:  M S Burnett; C A Gaydos; G E Madico; S M Glad; B Paigen; T C Quinn; S E Epstein
Journal:  J Infect Dis       Date:  2000-12-21       Impact factor: 5.226

9.  Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.

Authors:  N M Rothstein; T C Quinn; G Madico; C A Gaydos; C J Lowenstein
Journal:  J Infect Dis       Date:  2000-12-13       Impact factor: 5.226

10.  Quantitative assessment of atherosclerotic lesions in mice.

Authors:  B Paigen; A Morrow; P A Holmes; D Mitchell; R A Williams
Journal:  Atherosclerosis       Date:  1987-12       Impact factor: 5.162
View more
  11 in total

Review 1.  Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested.

Authors:  J Thomas Grayston; Robert J Belland; Gerald I Byrne; Cho Chou Kuo; Julius Schachter; Walter E Stamm; Guangming Zhong
Journal:  Pathog Dis       Date:  2014-12-04       Impact factor: 3.166

Review 2.  Infection and Atherosclerosis Development.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Arch Med Res       Date:  2015-05-21       Impact factor: 2.235

3.  Influence of intimal Chlamydophila pneumoniae persistence on cardiovascular complications after coronary intervention.

Authors:  I Tuleta; D Reek; P Braun; G Bauriedel; G Nickenig; D Skowasch; R Andrié
Journal:  Infection       Date:  2014-10-26       Impact factor: 3.553

4.  Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Leena Erkkilä; Taina Korhonen; Terttu Tiirola; Aini Bloigu; Pekka Saikku; Maija Leinonen
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

5.  Effects of murine norovirus on atherosclerosis in ldlr(-/-) mice depends on the timing of infection.

Authors:  Jisun Paik; Fiona Kwok; Audrey Seamons; Thea Brabb; Jinkyu Kim; Brittany Sullivan; Charlie Hsu; Kevin D O'Brien; Lillian Maggio-Price
Journal:  Comp Med       Date:  2015-04       Impact factor: 0.982

6.  Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells.

Authors:  Lee Ann Campbell; Mirja Puolakkainen; Amy Lee; Michael E Rosenfeld; H Jacques Garrigues; Cho-Chou Kuo
Journal:  Microbes Infect       Date:  2011-08-30       Impact factor: 2.700

7.  Tumor necrosis factor alpha plays a role in the acceleration of atherosclerosis by Chlamydia pneumoniae in mice.

Authors:  Lee Ann Campbell; Tadayoshi Nosaka; Michael E Rosenfeld; Kambiz Yaraei; Cho-Chou Kuo
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

8.  Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1.

Authors:  Lee A Campbell; Amy W Lee; Michael E Rosenfeld; Cho-Chou Kuo
Journal:  Pathog Dis       Date:  2013-10-01       Impact factor: 3.166

Review 9.  Inflammation and atherosclerosis: direct versus indirect mechanisms.

Authors:  Michael E Rosenfeld
Journal:  Curr Opin Pharmacol       Date:  2013-01-26       Impact factor: 5.547

10.  Identification and characterization of Chlamydia pneumoniae-specific proteins that activate tumor necrosis factor alpha production in RAW 264.7 murine macrophages.

Authors:  Shinn-Jong Jiang; Cho-Chou Kuo; Mark W Berry; Amy W Lee; Lee Ann Campbell
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.